H-FFC CCl4 Mouse

The H-FFC Cl4 mouse develops severe NASH with bridging fibrosis within 12 weeks

 

  • Mice are maintained on a diet high in fat, fructose and cholesterol (H-FFC) and dosed with CCl4 for 12 weeks
  • The H-FFC CCl4 mouse develops all the clinical histological endpoints associated with NASH including bridging fibrosis
  • Liver bioanalysis confirms the histological findings
  • Plasma AST is significantly increased

 

The H-FFC CCl4 mouse develops severe NASH and bridging fibrosis

 

The H-FFC CCL<sub>4</sub> mouse develops severe NASH and bridging fibrosis

Histopathology scoring of standard chow and H-FFC CCl4 mice. Data are presented as individual animal scores and means ± SEM.
Significant differences versus the standard chow vehicle group are denoted by ***p<0.001. The NAFLD activity score (NAS) was calculated by combining the scores for # parameters.

 

 

 

Sirius red stained liver – demonstrating the presence of bridging fibrosis

 

 

Histological endpoints are confirmed with liver bioanalysis, indicated by a significant increase in collagen, triglyceride and cholesterol content in the H-FFC CCl4. Plasma levels of the liver enzyme ALT is also significantly increased.

 

 

 

Liver biochemistry and terminal plasma analysis of standard chow and H-FFC CCl<sub>4</sub> mice.

Liver biochemistry and terminal plasma analysis of standard chow and H-FFC CCl4 mice.
Data are expressed as the means and SEM. Significant differences versus the standard chow group are denoted by **p<0.01 and ***p<0.001.

 

Get in touch to learn more about RenaSci’s H-FFC CCl4 mouse model of NASH and fibrosis.

 

Explore our other models of NASH

Contact us

For more details or information on how we can support your project please complete the contact form.